Advisors
Mark A. Creager, MD
Director, Vascular Center, Brigham and Women’s Hospital and Professor, Harvard Medical School
Robert Giugliano, MD
Assistant Professor, Harvard Medical School and Senior Investigator TIMI Study Group Brigham and Women’s Hospital
Business Advisors
John Dunn
Executive Vice President, New Ventures, Biogen Idec; formerly Senior Vice President and General Counsel of IDEC Pharmaceuticals, and Partner and co-lead Biotech, Pharmaceuticals and Healthcare Practice, Pillsbury Law.
David Hoey
Advisor to Healthcare Ventures Limited and Vice President, Business Development PathoGenetix Inc.; formerly Vice President, Business Development, US Genomics Inc. and Vice President Business Development, InfoLibria Inc.